Damien McDevitt (left), GSK vice president and head of the company’s research and development satellite in San Diego, and Jay Lichter, managing director of Avalon Ventures, work together to mitigate risk while fueling early-stage science.

Damien McDevitt (left), GSK vice president and head of the company’s research and development satellite in San Diego, and Jay Lichter, managing director of Avalon Ventures, work together to mitigate risk while fueling early-stage science. Photo by Avalon Ventures

Avalon Ventures announced the launch of three new biotech companies formed through its collaboration with British drugmaker GlaxoSmithKline...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129